Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Gastroenterology

Advertisement

Featured

News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Ultraprocessed Food Linked to Elevated Risk of CRC
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
Bill Chey
William Chey, MD, on the Role of Diet in Disorders of Gut-Brain Interaction
07/10/2024
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation on the role of diet in disorders of gut-brain interaction from Digestive Disease Week 2024.
Dr Chey reviews his presentation...
07/10/2024
Gastroenterology
FDA alert
FDA Alert
FDA Approves Risankizumab for Ulcerative Colitis
06/20/2024
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and Crohn's disease.
The approval makes risankizumab...
06/20/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Gut Check logo
Podcast
Gut Check: Drs Brian Lacy and Ami Sperber Delve Into DGBI
06/19/2024
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this episode of Gut Check, host Brian Lacy, MD, talks with Dr Ami Sperber about how disorders of gut-brain interaction can overlap, and how this can change treatment paradigms.
In this episode of Gut Check,...
06/19/2024
Gastroenterology
FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
Video
Kayla Monks, MS, RD, on Nutrition for Patients With Liver Disease
06/14/2024
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses nutritional needs and challenges of patients with liver disease, including candidates for transplant, and how to work with patients to achieve the best possible outcomes.
Kayla Monks, MS, RD, discusses...
06/14/2024
Gastroenterology
ALan Bonder
Podcast
Drs Alan Bonder and Robert Gish Discuss Screening and Treatment for Hepatitis D
06/05/2024
In this podcast, Drs Alan Bonder and Robert Gish discuss the need for universal screening for hepatitis D, the types of screening tests that should be used, and treatment options.
In this podcast, Drs Alan Bonder and Robert Gish discuss the need for universal screening for hepatitis D, the types of screening tests that should be used, and treatment options.
In this podcast, Drs Alan Bonder...
06/05/2024
Gastroenterology
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on the SEQUENCE Study
06/03/2024
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Dr Regueiro recaps the results from the pivotal study comparing the effects of risankizumab with ustekinumab on key biomarkers of inflammatory bowel disease, which he presented at Digestive Disease Week 2024.
Dr Regueiro recaps the results...
06/03/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network
Uma Mahadevan, MD
Conference Coverage
Uma Mahadevan, MD, on the PIANO Helmsley Consensus on IBD and Pregnancy
05/22/2024
Dr Mahadevan discusses the key findings of the PIANO Helmsley global consensus on pregnancy and inflammatory bowel disease, including preconception counseling, the safety of IBD medications during pregnancy and lactation, and more.
Dr Mahadevan discusses the key findings of the PIANO Helmsley global consensus on pregnancy and inflammatory bowel disease, including preconception counseling, the safety of IBD medications during pregnancy and lactation, and more.
Dr Mahadevan discusses the key...
05/22/2024
Advances in Inflammatory Bowel Disease Network
From Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

https://www.hmpgloballearningnetwork.com/site/ibd-app

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Ultraprocessed Food Linked to Elevated Risk of CRC
07/24/2024
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.
C olorectal cancer, colon...
07/24/2024
Gastroenterology
FDA alert
News
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
06/28/2024
The device can provide results in an hour from a fingertip blood test.
The device can provide results in an hour from a fingertip blood test.
The device can provide results...
06/28/2024
Gastroenterology
FDA alert
FDA Alert
Elafibranor Receives Accelerated FDA Approval for PBC
06/14/2024
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the first new medicine approved in nearly a decade for primary biliary cholangitis.
The first-in-class PPAR is the...
06/14/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
News
Multivariable Model Outperforms Guideline-Based Model for Predicting CRC
05/14/2024

Jolynn Tumolo

Jolynn Tumolo
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model was tested against a guideline-based model for classifying patients as low- or high-risk for colorectal cancer based solely on polyp characteristics.
A multivariable prediction model...
05/14/2024
Gastroenterology
News
CRC Rate Rising Among Younger Americans
05/14/2024

Rebecca Mashaw, Digital Managing Editor

Rebecca Mashaw, Digital Managing Edit...
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate of colorectal cancer remains among adults 40-44, escalation rates of CRC are highest among children, teens, and young adults.
While the highest incidence rate...
05/14/2024
Gastroenterology
News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024

Jolynn Tumolo

Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
News
H. Pylori Infection Studied for Association With Colorectal Cancer
03/12/2024

Jolynn Tumolo

Jolynn Tumolo
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter...
03/12/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement